MedTrace Logo

Navitian PMCF Study ( rEPIC04C )

NCT05292118 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2025-03-05

No results posted yet for this study

Summary

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Navitian to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Navitian.

Conditions

  • Coronary Artery Disease (CAD)
  • Ischemic Heart Disease

Interventions

DEVICE

Navitian

Patients in whom treatment with (Navitian) has been attempted

Sponsors & Collaborators

  • Fundación EPIC

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-26
Primary Completion
2024-07-11
Completion
2024-07-11

Countries

  • Portugal
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05292118 on ClinicalTrials.gov